In a randomised, comparative, parallel group study overweight diet-treated type 2 diabetic patients attending a teaching hospital in Peshawar, Pakistan, were assigned to 12 months of monotherapy with metformin (n=102) or glibenclamide (n=102) to investigate the effects of these agents on serum sialic acid (SSA). Drug treatment significantly improved glycaemic control and metformin treatment also appeared beneficial to other parameters monitored, significantly reducing triglycerides. Throughout the study SSA decreased in both treatment groups and there were no statistically significant differences between the groups. However, in the metformin-treated group SSA at 12 months was significantly lower than at baseline.
Schauer R.Sialic acids and their role as biological markers. Trends Biochem Sci1985;10:357-60.
2.
Ng S., Dain JAThe natural occurrence of sialic acids. In: Rosenberg A, Schengrund S (eds). Biological role of sialic acid. New York: Plenum, 1976;59-102.
3.
Chen JW, Gall MA, Yokohama H. et al. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care1996;19:130-4.
4.
Pickup JC, Mattock MB, Crook MA et al. Serum sialic acid concentration and coronary heart disease in NIDDM . Diabetes Care1995;18:1100-03.
5.
Vijay V., Snehalatha C., Ramachandran A., Jayaraman M.Serum sialic acid in South Indian type 2 diabetic patients with microvascular complications (Letter). Diabetic Med1998;15:176.
6.
Crook MA, Earle K., Morocutti A. et al. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria . Diabetes Care1994;17:305-09.
7.
Abdella N., Akanji AO, Mojiminiyi OA et al. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti type 2 diabetic patients . Diab Res Clin Pract2000;50:65-72.
8.
Islam N., Kazmi F., Chusney GD et al. Serum sialic acid and cardiovascular disease in Malay, Indian and Chinese subjects with NIDDM in Malaysia. Diabetes Res1997;31:77-85.
Lindberg G. , Rastam L., Gullber BO, Eklund GASerum sialic acid concentration predicts coronary heart disease and stroke mortality: multi-variate analysis including 54385 men and women during 30.5 years follow-up. Int J Epidemiol1992;21:253-7.
11.
Masuda H., Wakabayashi R., Wakabayashi I.Serum sialic acid and ankle versus brachial arterial pressure ratio in NIDDM . Scand J Clin Lab Invest1998;58:433-9.
12.
World Health Organization.Diet, nutrition and the prevention of chronic diseases. Report of a WHO study group. World Health Organ Tech Rep Ser1990;797:1-204.
13.
World Health Organization Expert Committee.Arterial hypertension. World Health Organ Tech Rep Ser1978;628.
14.
Shamberger RJSerum sialic acid in normal and cancer patients . Clin Chem Clin Biochem1984;22:64-7.
15.
Paterson AD , Rutledge BN, Cleary PA et al. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial ‘DCCT’/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care2007;30:2107-12.
16.
American Diabetes Association.Standards of medical care in diabetes. Position Statement. Diabetes Care2007;30:s4-s41.
17.
UK Prospective Diabetes Study Group ‘UKPDS 34’.Effect of intensive blood glucose control with metformin on complications in overweight patients with type2 diabetes. Lancet1998;7:854-65.
18.
Browning LM, Jebb SA, Mishra GD et al. Elevated sialic acid, but not CRP, predicts features of metabolic syndrome independently of BMI in women. Int J Obes Relat Met Disord2004;28:1004-10.
19.
Crook MA, Tutt P., Pickup JCElevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care1993;16:57-60.
20.
Wierzbicki AS, Nishtar S., Lumb PJ et al. Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Heart2005;91:1003-07.
21.
Deepa R., Rema M., Mohan V.Lack of association between serum sialic acid levels and retinopathy in type2 diabetic patients. Diab Res Clin Pract1998 ;41:165-69.
22.
Nayak SB, Bhaktha G.Relationship between sialic acid and metabolic variables in Indian type2 diabetic patients. Lipids Health Dis2005; 4:15.
23.
Lindberg G. , Iso H., Rastam L., Lundblad A., Folsam ARSerum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol1997;26:58-63.
